Cargando…

Vaccines - safety in pregnancy

Vaccination during pregnancy is important for active immunity of the mother against serious infectious diseases, and also for passive immunity of the neonate to infectious diseases with high morbidity and mortality. As a rule, live vaccines are contraindicated during pregnancy as they may cause feta...

Descripción completa

Detalles Bibliográficos
Autores principales: Arora, Mala, Lakshmi, Rama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2021
Materias:
3
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992376/
https://www.ncbi.nlm.nih.gov/pubmed/33773923
http://dx.doi.org/10.1016/j.bpobgyn.2021.02.002
_version_ 1783669359189688320
author Arora, Mala
Lakshmi, Rama
author_facet Arora, Mala
Lakshmi, Rama
author_sort Arora, Mala
collection PubMed
description Vaccination during pregnancy is important for active immunity of the mother against serious infectious diseases, and also for passive immunity of the neonate to infectious diseases with high morbidity and mortality. As a rule, live vaccines are contraindicated during pregnancy as they may cause fetal viremia/bacteremia. Inactivated vaccines are generally safe. Vaccines safe to be administered to all pregnant ladies are tetanus toxoid (TT; tetanus, diphtheria, acellular pertussis (Tdap) and Flu vaccines. During pre-pregnancy counselling, vaccination for MMR (measles, mumps, and rubella) should be offered, with an advice to avoid pregnancy for a month. All pregnant mothers should receive TT and Tdap vaccination during the third trimester. Flu vaccine can be given to all mothers at any gestation, and if not offered during pregnancy, it can be given postpartum. Vaccinations that should be offered to women if at high risk of exposure are for hepatitis A and B, pneumococcal, meningococcal, yellow fever, Japanese encephalitis (JE), polio, typhoid, and cholera infections. Vaccines to be given only for post-exposure prophylaxis (PEP) are smallpox, rabies, and anthrax. Postpartum women should be offered human papillomavirus (HPV) vaccination. If not immunized earlier, they should be offered MMR, Tdap, and Flu vaccines. Future vaccines being developed are for malaria, Zika virus, respiratory syncytial virus (RSV), group B streptococcus, CMV, and COVID-19 (SARS-Cov-2).
format Online
Article
Text
id pubmed-7992376
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-79923762021-03-26 Vaccines - safety in pregnancy Arora, Mala Lakshmi, Rama Best Pract Res Clin Obstet Gynaecol 3 Vaccination during pregnancy is important for active immunity of the mother against serious infectious diseases, and also for passive immunity of the neonate to infectious diseases with high morbidity and mortality. As a rule, live vaccines are contraindicated during pregnancy as they may cause fetal viremia/bacteremia. Inactivated vaccines are generally safe. Vaccines safe to be administered to all pregnant ladies are tetanus toxoid (TT; tetanus, diphtheria, acellular pertussis (Tdap) and Flu vaccines. During pre-pregnancy counselling, vaccination for MMR (measles, mumps, and rubella) should be offered, with an advice to avoid pregnancy for a month. All pregnant mothers should receive TT and Tdap vaccination during the third trimester. Flu vaccine can be given to all mothers at any gestation, and if not offered during pregnancy, it can be given postpartum. Vaccinations that should be offered to women if at high risk of exposure are for hepatitis A and B, pneumococcal, meningococcal, yellow fever, Japanese encephalitis (JE), polio, typhoid, and cholera infections. Vaccines to be given only for post-exposure prophylaxis (PEP) are smallpox, rabies, and anthrax. Postpartum women should be offered human papillomavirus (HPV) vaccination. If not immunized earlier, they should be offered MMR, Tdap, and Flu vaccines. Future vaccines being developed are for malaria, Zika virus, respiratory syncytial virus (RSV), group B streptococcus, CMV, and COVID-19 (SARS-Cov-2). Published by Elsevier Ltd. 2021-10 2021-02-19 /pmc/articles/PMC7992376/ /pubmed/33773923 http://dx.doi.org/10.1016/j.bpobgyn.2021.02.002 Text en © 2021 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle 3
Arora, Mala
Lakshmi, Rama
Vaccines - safety in pregnancy
title Vaccines - safety in pregnancy
title_full Vaccines - safety in pregnancy
title_fullStr Vaccines - safety in pregnancy
title_full_unstemmed Vaccines - safety in pregnancy
title_short Vaccines - safety in pregnancy
title_sort vaccines - safety in pregnancy
topic 3
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992376/
https://www.ncbi.nlm.nih.gov/pubmed/33773923
http://dx.doi.org/10.1016/j.bpobgyn.2021.02.002
work_keys_str_mv AT aroramala vaccinessafetyinpregnancy
AT lakshmirama vaccinessafetyinpregnancy